Pre-market · Regular session opens 9:30 AM ET
Last update: Oct 13, 2026, 6:14 PM ETTrending Tickers
The stocks moving most, ranked by their latest session change — across all 987 companies we track. Click any ticker for the full change report.
30D High
$85.90
30D Low
$13.30
30D Change
-84.45%
Risk Level
Medium
Most Significant Changes
Ranked by largest 1-day move
1

FRMIFermi Inc. Common Stock
$3.72▲ 14.46%30D: -34.85%
High: $5.71Low: $3.25Risk: High
54 changes
ActivityFermi Inc. announced a credit support agreement with AMD and a new partnership, according to AccessNewsWire. The stock surged 22.08% from $3.25 to $3.97 in early trading. Volume data remains unreliable 55 minutes into the session.today
2

CIFRCipher Mining Inc.
$11.34▼ 12.77%30D: -38.74%
High: $18.51Low: $11.34Risk: High
59 changes
ValuationCipher Mining announced a proposed $850 million private offering of 0.00% convertible senior notes due 2032, alongside a concurrent exchange of its 2030 convertible notes, according to a Globe Newswire release and SEC 8-K filing today. Investors reacted to dilution concerns and debt restructuring complexity, sending CIFR down 15.38% to $11.00 on elevated volume of 47.6M shares (5.07x the typical 110-minute average).today
3

PSPershing Square Inc.
$47.65▼ 12.12%30D: +14.85%
High: $54.22Low: $41.49Risk: High
50 changes
No changes detected this week
4

SMMTSummit Therapeutics Inc.
$15.52▼ 9.40%30D: -10.19%
High: $17.28Low: $15.52Risk: High
49 changes
ValuationSummit Therapeutics declined 6.74% to $15.97, driven by profit-taking and valuation consolidation following the completion of AstraZeneca's $2 billion equity investment, according to web sources. Traders are locking in gains ahead of crucial overall survival results for ivonescimab expected later in October, while broader market sentiment remains cautious amid rising oil prices.today
5

ASTSAST SpaceMobile, Inc.
$47.07▼ 8.53%30D: -28.81%
High: $66.12Low: $47.07Risk: High
56 changes
ValuationAST SpaceMobile shares fell 13.91% to $49.01 as SpaceX secured a low-band spectrum deal from Grain Management, closing off a critical expansion pathway for ASTS, per 247wallst.com. The move was amplified by elevated volume (21.7M shares, 6.46x normal for this time of day), with shares sliding to near their 52-week low of $48.82.4d ago
6

MIRMMirum Pharmaceuticals, Inc.
$79.62▼ 7.48%30D: -20.00%
High: $99.53Low: $79.62Risk: High
38 changes
ValuationMirum Pharmaceuticals (MIRM) fell 6.20% to $80.72 following a "sell-the-news" reaction after the company announced positive Phase 3 EXPAND study results for LIVMARLI on October 12, meeting its primary endpoint with a statistically significant reduction in itch severity (p=0.0004) and 69% drop in serum bile acids versus placebo. Morgan Stanley raised its price target to $152, yet investors trimmed near-term earnings forecasts and locked in profits ahead of the sNDA filing expected in H1 2027. Trading volume stands at 0.53x the time-adjusted average.today
7

FRVOFervo Energy Company
$11.98▼ 6.92%30D: -36.61%
High: $18.90Low: $11.98Risk: High
61 changes
RiskA new report scrutinizing Fervo Energy's geothermal narrative circulated via PR Newswire, questioning the company's positioning and highlighting that the stock trades 46% below its IPO price. FRVO fell 6.68% intraday to $12.01 on volume 1.28x normal for this time of day.today
8

AMATApplied Materials, Inc.
$464.24▼ 6.69%30D: -1.81%
High: $497.53Low: $464.24Risk: High
94 changes
ValuationApplied Materials, Inc. moved -5.07% intraday from $497.53 to $472.32. Applied Materials (AMAT) stock is down roughly 5% at around $472.63 per share. ### Key Factors Driving the Drop - "Sell the News" Reaction to the EPIC Center: Investors reacted with disappointment after Applied Materials unveiled its new $5 billion Equipment and Process Innovation and Commercialization (EPIC) Center in Sunnyvale, California. While major partners like TSMC, Samsung, and Intel signed on, the announcement lacked immediate new equipment orders or clear short-term financial details. - Supply Chain Warnings: Ahead of the SEMICON West conference, Citi flagged potential supply chain bottlenecks—such as shortages in DRAM memory, capacitors, and optical components—that could temporarily slow down equipment spending ramps. - Elevated Valuation: Trading around 40 times earnings, the stock has left little room for near-term errors, prompting profit-taking as broader tech and semiconductor sectors face pressure. Would you like more details on AMAT's upcoming earnings date in November or analyst price targets?today
9

SSRMSSR Mining Inc.
$33.09▼ 6.63%30D: -10.42%
High: $36.94Low: $33.09Risk: High
40 changes
RiskSSR Mining announced the acquisition of Roxmore Resources via Business Wire today, alongside a separate announcement of a 20-year Life of Mine plan for its Marigold project with an expanded 4.6 million ounce mineral reserve. Despite these typically constructive developments, the stock declined 6.43% from $35.44 to $33.16 intraday on above-average volume (1.87x normal for this point in the session), suggesting the market is pricing in dilution or execution risk from the Roxmore deal or weighting near-term cash flow constraints.today
10

AXSMAxsome Therapeutics, Inc.
$156.32▼ 5.83%30D: -24.78%
High: $207.82Low: $156.32Risk: High
38 changes
ValuationAxsome Therapeutics extended a multi-day losing streak as part of a sector-wide pullback in growth-oriented biotech stocks amid macro headwinds—specifically surging oil prices and rising Treasury yields pressuring risk-on equities. AXSM fell 4.95% to $157.79 intraday on volume 1.49x the 120-minute average, contributing to a cumulative drop of roughly 14% over an 11-session stretch through mid-October 2026.today
11

JNJJohnson & Johnson
$248.61▼ 5.73%30D: -7.62%
High: $269.12Low: $248.61Risk: High
69 changes
RiskJohnson & Johnson (JNJ) fell 6.81% to $245.78 following Q3 earnings released today, despite beating revenue and adjusted EPS estimates and raising full-year 2026 guidance to $11.05–$11.15. The sell-off was driven by a sharp drop in reported net profit and weakness in the MedTech segment—pressured partly by Middle East conflict disrupting device sales—which overshadowed strong pharmaceutical performance, per reporting on the earnings release.today
12

CDWCDW Corporation
$151.97▲ 5.71%30D: +5.18%
High: $151.97Low: $143.76Risk: High
34 changes
No changes detected this week
13

COGTCogent Biosciences, Inc.
$28.09▼ 5.67%30D: -20.38%
High: $35.28Low: $28.09Risk: High
39 changes
ValuationCogent Biosciences fell 3.93% to $28.61, with selling pressure linked to insider transactions reported by established finance sources (Yahoo Finance, Investing.com). Volume remained below average at 0.69x the expected pace 170 minutes into the session, suggesting limited institutional participation in the decline.today
14

AURAurora Innovation, Inc.
$5.34▼ 5.65%30D: -17.97%
High: $6.51Low: $5.34Risk: High
41 changes
No changes detected this week
15

CCitigroup Inc.
$124.53▼ 5.60%30D: -8.93%
High: $136.74Low: $124.53Risk: High
39 changes
ValuationCitigroup reported better-than-expected Q3 2026 earnings (adjusted EPS of $2.85 vs. $2.65–$2.66 consensus; revenue $23.85B, +8% YoY) before the open, but shares fell 3.75% to $126.97 by mid-session (Business Wire). The decline was driven by caution over reliance on cyclical FICC trading revenue ($4.4B) and Citigroup's own morning downgrade of U.S. equities from overweight due to market exuberance and historical peak valuations, adding a risk-off tone despite the earnings beat. Volume running 1.96x normal for this time of session.today
16

PCVXVaxcyte, Inc.
$66.80▼ 5.45%30D: +10.67%
High: $70.65Low: $60.36Risk: High
37 changes
Material / EarningsVaxcyte, Inc. (PCVX) moved +10.19% from $64.78 to $71.38 on 2026-10-09. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move occurred on typical trading activity.4d ago
17

KRMNKarman Holdings Inc.
$30.15▼ 5.43%30D: -24.04%
High: $39.69Low: $30.15Risk: High
50 changes
ValuationKarman Holdings extended a multi-week decline to new 52-week lows around $32.15, driven by persistent concerns raised in a JCap short-seller report questioning the company's cash flow generation despite revenue growth, combined with prior disclosures of internal control weaknesses and an upsized secondary offering (ng.investing.com, uk.investing.com). KRMN fell 4.78% to $30.36 on below-average volume of 916K shares (0.49x expected for this time).today
18

VGVenture Global, Inc.
$13.84▲ 5.41%30D: -6.04%
High: $14.73Low: $13.13Risk: Medium
45 changes
No changes detected this week
19

TTMITTM Technologies, Inc.
$116.10▲ 5.23%30D: -10.24%
High: $129.35Low: $110.33Risk: High
47 changes
RiskTTM Technologies shares fell 6.91% to $112.65, driven by factors cited across Yahoo Finance and Investing.com on October 12, 2026. The decline occurred early in the session with volume data not yet reliably established.1d ago
20

PLPlanet Labs PBC
$15.16▼ 5.01%30D: -14.88%
High: $17.81Low: $15.16Risk: High
43 changes
ValuationPlanet Labs fell 4.58% to $15.23 amid sector-wide pressure in space stocks and macroeconomic headwinds from elevated Treasury yields, according to analysis citing the stock's sensitivity to broader risk-off rotation in high-growth technology equities. Peer names including AST SpaceMobile and Rocket Lab also declined on the day. Volume reached 4.3M shares (1.43x normal for this time of session), reflecting moderate activity.today
21

TPGTPG Inc.
$42.89▼ 4.94%30D: -15.75%
High: $50.91Low: $42.89Risk: High
30 changes
No changes detected this week
22

KYMRKymera Therapeutics, Inc.
$106.68▼ 4.82%30D: -8.41%
High: $116.47Low: $106.68Risk: High
38 changes
No changes detected this week
23

ACMRACM Research, Inc.
$64.83▼ 4.80%30D: -15.71%
High: $76.91Low: $64.83Risk: High
46 changes
No changes detected this week
24

PTCTPTC Therapeutics, Inc.
$59.92▼ 4.77%30D: -12.92%
High: $68.81Low: $59.92Risk: High
30 changes
No changes detected this week
25

DPZDomino's Pizza, Inc.
$296.10▼ 4.76%30D: -11.72%
High: $335.41Low: $296.10Risk: Low
40 changes
No changes detected this week
26

KKRKKR & Co. Inc.
$87.16▼ 4.75%30D: -17.56%
High: $105.73Low: $87.16Risk: Medium
36 changes
No changes detected this week
27

VLOValero Energy Corporation
$456.46▲ 4.69%30D: +19.23%
High: $456.46Low: $382.85Risk: High
53 changes
No changes detected this week
28

NXTNextpower Inc.
$88.77▲ 4.61%30D: +3.89%
High: $88.77Low: $84.86Risk: High
46 changes
No changes detected this week
29

PINSPinterest, Inc.
$22.37▲ 4.44%30D: +11.07%
High: $22.37Low: $20.14Risk: High
48 changes
No changes detected this week
30

NBIXNeurocrine Biosciences, Inc.
$135.13▼ 4.41%30D: -12.89%
High: $155.13Low: $135.13Risk: High
30 changes
No changes detected this week
Change Categories
Types of changes detected this week
Material / Earnings4
Activity7
Risk27
Side-by-Side Comparison
30-day snapshot across all tracked stocks
Symbol
Price
1D %
30D %
30D High
30D Low
Risk
Changes

$3.72
▲ 14.46%
▼ 34.85%
$5.71
$3.25
High
54

$11.34
▼ 12.77%
▼ 38.74%
$18.51
$11.34
High
59

$47.65
▼ 12.12%
▲ 14.85%
$54.22
$41.49
High
50

$15.52
▼ 9.40%
▼ 10.19%
$17.28
$15.52
High
49

$47.07
▼ 8.53%
▼ 28.81%
$66.12
$47.07
High
56

$79.62
▼ 7.48%
▼ 20.00%
$99.53
$79.62
High
38

$11.98
▼ 6.92%
▼ 36.61%
$18.90
$11.98
High
61

$464.24
▼ 6.69%
▼ 1.81%
$497.53
$464.24
High
94

$33.09
▼ 6.63%
▼ 10.42%
$36.94
$33.09
High
40

$156.32
▼ 5.83%
▼ 24.78%
$207.82
$156.32
High
38

$248.61
▼ 5.73%
▼ 7.62%
$269.12
$248.61
High
69

$151.97
▲ 5.71%
▲ 5.18%
$151.97
$143.76
High
34

$28.09
▼ 5.67%
▼ 20.38%
$35.28
$28.09
High
39

$5.34
▼ 5.65%
▼ 17.97%
$6.51
$5.34
High
41

$124.53
▼ 5.60%
▼ 8.93%
$136.74
$124.53
High
39

$66.80
▼ 5.45%
▲ 10.67%
$70.65
$60.36
High
37

$30.15
▼ 5.43%
▼ 24.04%
$39.69
$30.15
High
50

$13.84
▲ 5.41%
▼ 6.04%
$14.73
$13.13
Medium
45

$116.10
▲ 5.23%
▼ 10.24%
$129.35
$110.33
High
47

$15.16
▼ 5.01%
▼ 14.88%
$17.81
$15.16
High
43

$42.89
▼ 4.94%
▼ 15.75%
$50.91
$42.89
High
30

$106.68
▼ 4.82%
▼ 8.41%
$116.47
$106.68
High
38

$64.83
▼ 4.80%
▼ 15.71%
$76.91
$64.83
High
46

$59.92
▼ 4.77%
▼ 12.92%
$68.81
$59.92
High
30

$296.10
▼ 4.76%
▼ 11.72%
$335.41
$296.10
Low
40

$87.16
▼ 4.75%
▼ 17.56%
$105.73
$87.16
Medium
36

$456.46
▲ 4.69%
▲ 19.23%
$456.46
$382.85
High
53

$88.77
▲ 4.61%
▲ 3.89%
$88.77
$84.86
High
46

$22.37
▲ 4.44%
▲ 11.07%
$22.37
$20.14
High
48

$135.13
▼ 4.41%
▼ 12.89%
$155.13
$135.13
High
30

$138.49
▼ 4.41%
▼ 5.10%
$145.94
$138.49
High
27

$106.95
▲ 4.36%
▼ 26.62%
$145.74
$102.48
High
56

$128.23
▲ 4.33%
▲ 18.39%
$128.23
$108.31
Low
46

$485.22
▼ 4.30%
▼ 8.26%
$528.90
$485.22
Medium
27

$58.13
▼ 4.28%
▼ 31.70%
$85.11
$58.13
High
38

$34.73
▼ 4.25%
▼ 14.18%
$40.47
$34.73
High
66

$202.35
▲ 4.24%
▼ 9.05%
$222.49
$194.12
High
47

$151.87
▼ 4.24%
▼ 21.25%
$192.85
$151.87
High
30

$143.20
▲ 4.23%
▼ 11.89%
$162.52
$137.39
High
68

$156.54
▼ 4.21%
▲ 2.00%
$163.42
$153.47
High
102

$109.98
▼ 4.18%
▼ 17.91%
$133.97
$109.98
High
42

$334.20
▼ 4.08%
▲ 17.63%
$348.42
$284.11
Medium
40

$200.32
▼ 4.07%
▼ 6.08%
$213.29
$200.32
High
37

$92.37
▲ 4.01%
▼ 5.93%
$98.19
$88.81
High
31

$292.73
▲ 4.00%
▲ 12.96%
$292.73
$259.14
High
45

$476.98
▲ 3.96%
▲ 19.91%
$476.98
$397.77
High
47

$61.02
▼ 3.92%
▼ 19.31%
$75.62
$61.02
High
47

$16.18
▼ 3.92%
▼ 20.92%
$20.46
$16.18
High
40

$186.60
▲ 3.83%
▼ 12.50%
$213.25
$179.72
High
45

$88.20
▲ 3.81%
▲ 3.01%
$88.20
$84.96
Medium
15
Recent Change Activity
All changes in the past 7 days
Valuation

MIRM
Mirum Pharmaceuticals (MIRM) fell 6.20% to $80.72 following a "sell-the-news" reaction after the company announced positive Phase 3 EXPAND study results for LIVMARLI on October 12, meeting its primary endpoint with a statistically significant reduction in itch severity (p=0.0004) and 69% drop in serum bile acids versus placebo. Morgan Stanley raised its price target to $152, yet investors trimmed near-term earnings forecasts and locked in profits ahead of the sNDA filing expected in H1 2027. Trading volume stands at 0.53x the time-adjusted average.
today
Risk

ONTO
Onto Innovation fell 6.03% to $257.22 as semiconductor equipment stocks experienced broad profit-taking and technical breakdown. According to web searches, ONTO is caught in synchronized selling across the semiconductor sector following a strong multi-month rally, with technical indicators slipping below key support levels and triggering momentum-driven selling (ca.investing.com, finance.yahoo.com). Volume of 452,001 shares is running at 0.87x historical average for this time of session—within normal range.
today
Valuation

UCTT
Ultra Clean Holdings fell 6.13% to $59.62 as part of a broad-based semiconductor sector selloff driven by AI trade overheating concerns and valuation jitters, per Reuters and Seeking Alpha reporting on October 13. No company-specific negative news triggered the decline; UCTT is sliding in lockstep with major chipmaking-equipment peers amid profit-taking after year-to-date gains.
today
Valuation

KRMN
Karman Holdings extended a multi-week decline to new 52-week lows around $32.15, driven by persistent concerns raised in a JCap short-seller report questioning the company's cash flow generation despite revenue growth, combined with prior disclosures of internal control weaknesses and an upsized secondary offering (ng.investing.com, uk.investing.com). KRMN fell 4.78% to $30.36 on below-average volume of 916K shares (0.49x expected for this time).
today
Valuation

COGT
Cogent Biosciences fell 3.93% to $28.61, with selling pressure linked to insider transactions reported by established finance sources (Yahoo Finance, Investing.com). Volume remained below average at 0.69x the expected pace 170 minutes into the session, suggesting limited institutional participation in the decline.
today
Risk

FORM
FormFactor filed a material event 8-K today, triggering a 6.2% intraday decline to $122.20 from $130.28 (SEC filing_snapshots). The nature of the material event is not yet disclosed in the available evidence, but the filing's timing coincides with the sharp selloff in early trading.
today
Risk

AAOI
Applied Optoelectronics fell 5.53% to $95.11 amid a broader pullback in optical networking and AI infrastructure stocks, as cited by Yahoo Finance. The decline reflects sector-wide caution over valuation concerns, AI spending uncertainties, and lingering sentiment from the company's $600 million at-the-market equity offering completed earlier. Peers including Lumentum and Coherent have also experienced recent volatility as investors reassess AI hardware and optical interconnect valuations.
today
Risk

LRCX
Lam Research declined 5.40% to $292.84 intraday with no identified company-specific catalyst in news or filings today. Volume remains at 1.00x the typical pace for this time of session, suggesting broad-market or sector-wide pressure rather than localized selling.
today
Valuation

VIAV
VIAV fell 6.62% to $38.98, driven by profit-taking and valuation concerns following a multi-month surge, according to the web catalyst. Although the company announced today that its T/Rx system was selected by the U.S. Army Threat Systems Management Office for a critical range modernization initiative (PR Newswire), the positive news was overshadowed by a broader pullback; the stock declined 8.2% in the prior session and continues sliding as investors lock in gains amid flagged high valuation multiples and increased insider selling.
today
Valuation

PL
Planet Labs fell 4.58% to $15.23 amid sector-wide pressure in space stocks and macroeconomic headwinds from elevated Treasury yields, according to analysis citing the stock's sensitivity to broader risk-off rotation in high-growth technology equities. Peer names including AST SpaceMobile and Rocket Lab also declined on the day. Volume reached 4.3M shares (1.43x normal for this time of session), reflecting moderate activity.
today
Risk

SSRM
SSR Mining announced the acquisition of Roxmore Resources via Business Wire today, alongside a separate announcement of a 20-year Life of Mine plan for its Marigold project with an expanded 4.6 million ounce mineral reserve. Despite these typically constructive developments, the stock declined 6.43% from $35.44 to $33.16 intraday on above-average volume (1.87x normal for this point in the session), suggesting the market is pricing in dilution or execution risk from the Roxmore deal or weighting near-term cash flow constraints.
today
Valuation

AMAT
Applied Materials, Inc. moved -5.07% intraday from $497.53 to $472.32. Applied Materials (AMAT) stock is down roughly 5% at around $472.63 per share. ### Key Factors Driving the Drop - "Sell the News" Reaction to the EPIC Center: Investors reacted with disappointment after Applied Materials unveiled its new $5 billion Equipment and Process Innovation and Commercialization (EPIC) Center in Sunnyvale, California. While major partners like TSMC, Samsung, and Intel signed on, the announcement lacked immediate new equipment orders or clear short-term financial details. - Supply Chain Warnings: Ahead of the SEMICON West conference, Citi flagged potential supply chain bottlenecks—such as shortages in DRAM memory, capacitors, and optical components—that could temporarily slow down equipment spending ramps. - Elevated Valuation: Trading around 40 times earnings, the stock has left little room for near-term errors, prompting profit-taking as broader tech and semiconductor sectors face pressure. Would you like more details on AMAT's upcoming earnings date in November or analyst price targets?
today
Valuation

ANET
Arista Networks fell 5.30% to $199.70 intraday on elevated volume (2.61x average for this time of day), cited by Google's AI Overview as a notable move on October 13, 2026 (per finance.yahoo.com). No specific catalyst article detailing the driver was captured in today's evidence, though the stock had gained 12% over the prior month before this reversal.
today
Valuation

C
Citigroup reported better-than-expected Q3 2026 earnings (adjusted EPS of $2.85 vs. $2.65–$2.66 consensus; revenue $23.85B, +8% YoY) before the open, but shares fell 3.75% to $126.97 by mid-session (Business Wire). The decline was driven by caution over reliance on cyclical FICC trading revenue ($4.4B) and Citigroup's own morning downgrade of U.S. equities from overweight due to market exuberance and historical peak valuations, adding a risk-off tone despite the earnings beat. Volume running 1.96x normal for this time of session.
today
Valuation

SMMT
Summit Therapeutics declined 6.74% to $15.97, driven by profit-taking and valuation consolidation following the completion of AstraZeneca's $2 billion equity investment, according to web sources. Traders are locking in gains ahead of crucial overall survival results for ivonescimab expected later in October, while broader market sentiment remains cautious amid rising oil prices.
today
Valuation

CRDO
Credo Technology (CRDO) fell 6.23% to $188.33 amid profit-taking and valuation concerns in high-beta AI infrastructure stocks, compounded by reports of next-generation product shipment delays into 2027 and recent insider selling via 10b5-1 plans (defenseworld.net, 247wallst.com). The decline reflects rotation away from stretched multiples and fresh caution around customer concentration and gross margin pressure.
today
Risk

FRVO
A new report scrutinizing Fervo Energy's geothermal narrative circulated via PR Newswire, questioning the company's positioning and highlighting that the stock trades 46% below its IPO price. FRVO fell 6.68% intraday to $12.01 on volume 1.28x normal for this time of day.
today
Activity

FRMI
Fermi Inc. announced a credit support agreement with AMD and a new partnership, according to AccessNewsWire. The stock surged 22.08% from $3.25 to $3.97 in early trading. Volume data remains unreliable 55 minutes into the session.
today
Valuation

AXSM
Axsome Therapeutics extended a multi-day losing streak as part of a sector-wide pullback in growth-oriented biotech stocks amid macro headwinds—specifically surging oil prices and rising Treasury yields pressuring risk-on equities. AXSM fell 4.95% to $157.79 intraday on volume 1.49x the 120-minute average, contributing to a cumulative drop of roughly 14% over an 11-session stretch through mid-October 2026.
today
Valuation

CIFR
Cipher Mining announced a proposed $850 million private offering of 0.00% convertible senior notes due 2032, alongside a concurrent exchange of its 2030 convertible notes, according to a Globe Newswire release and SEC 8-K filing today. Investors reacted to dilution concerns and debt restructuring complexity, sending CIFR down 15.38% to $11.00 on elevated volume of 47.6M shares (5.07x the typical 110-minute average).
today
Material / Earnings

GS
The Goldman Sachs Group, Inc. (GS) reported EPS of $17.01 vs. $12.86 consensus estimate for Q3 FY2026, beating by 32.3%.
today
Risk

JNJ
Johnson & Johnson (JNJ) fell 6.81% to $245.78 following Q3 earnings released today, despite beating revenue and adjusted EPS estimates and raising full-year 2026 guidance to $11.05–$11.15. The sell-off was driven by a sharp drop in reported net profit and weakness in the MedTech segment—pressured partly by Middle East conflict disrupting device sales—which overshadowed strong pharmaceutical performance, per reporting on the earnings release.
today
Valuation

ASTS
AST SpaceMobile fell 6.60% to $48.07 following intensifying competitive pressure from SpaceX's direct-to-cell spectrum acquisitions and FCC approvals, combined with analyst downgrades—most notably Piper Sandler's cut to Neutral and $54 price target (down from $98), citing heightened competitive risks and lower conviction in near-term launch timelines, per Yahoo Finance and Seeking Alpha.
today
Valuation

OKLO
Oklo fell 6.77% to $32.35 as nuclear energy and small modular reactor (SMR) stocks retreated broadly, with peer NuScale Power sliding similarly (247wallst.com, zacks.com). The sector-wide pullback reflects investor caution on pre-revenue nuclear developers facing extended timelines before commercial deployments and rising cash burn projections of $120–$150 million for 2026 (web_catalyst). Volume of 7.76M shares traded at 0.75x historical average, suggesting below-average participation at this session stage.
1d ago
Valuation

VSAT
VSAT fell 6.03% to $67.67 amid profit-taking after a 9.1% surge on Friday following Raymond James's Outperform reiteration, combined with a broader sector selloff in satellite and networking hardware (per web sources including Barron's coverage of VSAT volatility on Feb 11, 2025) and insider selling disclosures. Volume of 966k shares ran 0.60x below average for this point in the session.
1d ago
Valuation

SAIL
SailPoint fell 6.16% to $19.49 following insider selling activity disclosed in Form 4 filings; the company's Chief Accounting Officer Mitra Rezvan sold 23,360 shares on October 12 (per investing.com). Despite Stephens raising its price target on progress in SailPoint's identity platform (uk.investing.com), the stock declined on the insider transaction. Volume stood at 0.63x expected for this point in the session, indicating below-average trading interest.
1d ago
Valuation

ALAB
Astera Labs fell 6.22% to $320.93 on analyst downgrade and sector-wide de-risking. Northland Securities downgraded ALAB from Outperform to Market Perform, citing elevated valuation (trailing P/E >160x) and heightened sensitivity to pullbacks in high-beta semiconductor and AI-infrastructure stocks. Despite the company announcing new initiatives including the Orion rack-scale architecture and a PCIe-over-optics demo partnership with Lumentum and Corning on the same day, investors locked in profits ahead of November 3 earnings. Volume of 2.09M shares was 0.57x expected for this time of session.
1d ago
Valuation

PL
Planet Labs stock fell 6.02% to $16.14 amid macroeconomic headwinds, elevated Treasury yields (10-year near 5.3%), and investor concerns over valuation and dilution from its $1.5 billion at-the-market equity offering, per Benzinga and Yahoo Finance. Volume remains below average at 0.60x the typical pace 290 minutes into the session.
1d ago
Valuation

CVNA
Carvana (CVNA) fell 5.41% to $60.28 as investors adopt a cautious stance ahead of the company's Q3 earnings report (scheduled Oct. 28, 2026) amid broader market pullbacks and sector-wide concerns about agentic AI's potential impact on online auto retail. Volume remained below average at 0.70x expected for this point in the session, per FMP data, suggesting measured selling rather than panic liquidation.
1d ago
Valuation

VSXY
Victoria's Secret & Company moved +6.62% intraday from $82.87 to $88.36. Victoria’s Secret & Co. (VSXY) stock is up 6.62% today, trading at $88.36 , primarily driven by renewed buying interest from investors taking advantage of a perceived valuation discount and a broadly supportive tone in equity markets as the Q3 earnings season begins.The stock is clawing back ground after a steep 13% post-earnings selloff in early September. Today's rally is further reinforced by a Wall Street consensus note highlighting a "Moderate Buy" collective rating from 14 analyst firms, with an average 12-month target price of $89.91. ## Victoria's Secret & Co (VSXY) $88.36 6.62% today As of Oct 12, 12:50 PM EDT • Disclaimer 9:35 AM 10:35 AM 11:35 AM 12:35 PM 84 86 88 Prev close $82.87 Oct 12, 2026 9:35 AM - 12:50 PM 1D 5D 1M 6M YTD 1Y 5Y Max| Open 83.33 | Mkt cap $6.97B USD | 52-wk high 102.46 | | High 87.98 | P/E ratio 20.61 | 52-wk low 71.72 | | Low 82.93 | Div yield- | ### Key Market Factors: - Turnaround Momentum: Investors are displaying renewed confidence in CEO Hillary Super’s strategic shift to revitalize the brand. Despite the post-earnings pullback in September, the underlying business showed a strong 10% year-over-year increase in net sales to $1.61 billion and n
1d ago
Valuation

COMP
Compass, Inc. (COMP) fell 5.43% to $8.88 amid a confluence of legal and regulatory pressures: fresh antitrust and MLS scrutiny in Texas alongside ongoing listing-data disputes with Zillow, per the web catalyst. Simultaneously, multiple securities class-action lawsuits were announced via PR Newswire (DJS Law Group, Robbins LLP), citing alleged securities law violations. Trading volume stood at 5.18M shares (0.59x expected for this time of day), below average.
1d ago
Valuation

MXL
MaxLinear shares fell 6.91% to $89.52 as part of a broader semiconductor and AI-hardware sector pullback driven by macro headwinds—rising Treasury yields and renewed U.S. semiconductor tariff concerns—combined with profit-taking following the stock's extraordinary multi-hundred-percent rally year-to-date. Volume at 1.11x normal intraday average reflects the rotation. No company-specific negative news has been reported.
1d ago
Valuation

LGN
Legence (LGN) fell 3.20% to $49.88 on analyst downside pressure: Stifel Nicolaus (analyst Brian Brophy) lowered its price target to $82.00 on October 8, 2026, maintaining a Buy rating but signaling reduced near-term upside. The decline also reflects lingering headwinds from Q2 earnings that included $41.08 million in asset impairments and ongoing private equity stake reductions by Blackstone. Volume sits at 0.56x expected for this stage of the session, indicating below-average engagement.
1d ago
Valuation

MTSI
MACOM (MTSI) fell 6.08% to $309.99, driven by a combination of sector-wide AI chip reassessment—major industry players issued cautious AI revenue guidance, stoking concerns about unsustainable hyperscale infrastructure spending—and recent insider selling by SVP Ambra Roth (Form 4 filing per Investing.com). The decline also reflects profit-taking pressure on a stock that had surged 170% over the trailing year and 93% year-to-date, with a P/E ratio near 99.35 making it vulnerable to valuation resets. Volume at 404,716 shares is 0.84x expected for this time of day.
1d ago
Valuation

MP
MP Materials Corp. moved -5.05% intraday from $46.14 to $43.81. MP Materials Corp. (NYSE: MP) stock is under pressure as investors weigh strong production growth against continued losses, rich valuation metrics, and recent analyst price target cuts. - Analyst Downgrades & Target Cuts: Wall Street firm Morgan Stanley recently lowered its price target on MP stock, and Wall Street Zen downgraded the stock rating to "Sell", dampening near-term sentiment. - Valuation and Profitability Concerns: Investors continue to debate whether the domestic rare-earth buildout can convert production scale into durable, immediate net profits ahead of the company's upcoming third-quarter earnings report scheduled for November 5, 2026. - Sector-Wide Softness: Rare-earth and strategic metals have experienced broader sector pullbacks as the market digests the timeline for upcoming commercial magnet deliveries (such as initial shipments to General Motors). If you want, let me know: - Are you looking for details on MP's upcoming Q3 2026 earnings? - Do you want to see how MP's valuation compares to other rare-earth peers?
1d ago
Valuation

RGTI
RGTI fell 4.70% to $13.37 following a broader quantum computing sector selloff triggered by IonQ's 9% decline after announcing an all-stock acquisition of cybersecurity firm Elisity worth up to $1.3B (247wallst.com, 2026-10-12). D-Wave and Rigetti both fell approximately 4% in sympathy, suggesting sector-wide investor concern over dilution and capital allocation in the quantum computing space. Volume of 4.37M shares ran 1.23x normal for this point in the session.
1d ago
Valuation

FRVO
Fervo Energy (FRVO) declined 3.64% to $13.25, continuing a broader downward trend driven by operational and financial scrutiny. Per the web catalyst, the stock remains pressured by transmission curtailment risks at its Cape Station project (revealed in Q2 2026 earnings on August 12, 2026) and investor investigations into disclosures around transmission risks and thermal decline announced in early October 2026. The stock has fallen sharply from its $27 IPO price in May 2026, as the market rebalances valuation against high early-stage capex and EBITDA losses.
1d ago
Valuation

JOBY
Joby Aviation plunged 4.04% to $5.22 as of midday, extending a broader selloff driven by a Barclays downgrade to Underweight with a $4.00 price target (citing manufacturing scale concerns), combined with a $1.169 billion court verdict in a trade secrets case, per Reuters and Yahoo Finance. The stock has fallen 12.42% since October 1 and now trades at a 52-week low, with volume at 1.22x normal for the time of day.
1d ago
Valuation

MANH
Morgan Stanley upgraded Manhattan Associates to Overweight from Equalweight and raised its price target to $250 from $180, citing accelerating cloud subscription bookings and a shift in investor narrative from AI-vulnerable to AI-beneficiary (investing.com). MANH surged 6.01% to $217.20 on elevated volume of 2.76x the historical average, with positioning ahead of Q3 earnings scheduled for October 27.
1d ago
Valuation

SNAP
Snap surged 5.70% to $6.58 following activist investor Blue Duck Capital's open letter urging the board to unlock value in its Specs AR glasses unit through a spin-off or standalone financing, according to web sources. The move is underpinned by unusually heavy bullish options activity—nearly double average volume—with out-of-the-money call options dominating ahead of the November 4 earnings report.
1d ago
Valuation

UCTT
Ultra Clean Holdings declined 4.83% to $65.28 despite a Seeking Alpha rating upgrade published today, which argued for a more positive view on the stock (Seeking Alpha). The disconnect between positive analyst commentary and intraday selling pressure suggests investors may be reacting to near-term headwinds or profit-taking rather than embracing the upgrade. Volume remains normal at 1.02x the historical average.
1d ago
Valuation

FRMI
Fermi Inc. declined 5.10% to $3.25, continuing a downward trend near 52-week lows amid investor caution tied to past tenant agreement delays and pre-revenue losses from Project Matador development, according to investing.com and ng.investing.com. The stock has fallen 89% from its 52-week high of $32.39. Volume of 5.19M shares is running at 0.98x the time-adjusted average, indicating normal trading activity.
1d ago
Valuation

LW
Lamb Weston rebounded +3.51% to $49.55, extending gains from its October 6 Q1 FY2027 earnings beat (EPS $0.75 vs. $0.59 consensus) and raised full-year guidance to $3.05–$3.35 per share, per the web catalyst and Seeking Alpha report. The stock had dipped ~3.2% on October 9 before today's relief rally. Volume of 1.24M shares is 1.54x historical average for this time of session.
1d ago
Valuation

SMTC
Semtech Corporation fell 7.05% to $174.09 on intraday trading, though no immediate catalyst event or news announcement is evident in available sources as of 45 minutes into the session. The decline occurs ahead of an upcoming Data Center Analyst Day scheduled for October 15, 2026, and Q3 earnings due November 23, 2026.
1d ago
Risk

AKAM
Akamai Technologies fell 5.92% to $100.62, touching a 52-week low amid broader market shifts (investing.com). The decline follows recent earnings-related activity and occurs as the stock approaches key support levels.
1d ago
Valuation

CIEN
Ciena fell 10.60% to $402.09 amid a sector-wide pullback in AI infrastructure and optical networking stocks, per Investing.com. The decline reflects profit-taking after a strong multi-week rally and high valuation multiples relative to historical and peer averages, compounded by weakness across peers like Lumentum and Coherent around industry events such as the OCP Global Summit. Volume remained normal at 1.01x expected for this time of session.
1d ago
Risk

TTMI
TTM Technologies shares fell 6.91% to $112.65, driven by factors cited across Yahoo Finance and Investing.com on October 12, 2026. The decline occurred early in the session with volume data not yet reliably established.
1d ago
Risk

LITE
Lumentum announced a joint demonstration with Astera Labs and Corning of 1060 nm VCSEL-based PCIe over Optics technology for AI connectivity at the 2026 OCP Global Summit (Business Wire, 2026-10-12). The stock fell 6.03% from $1103.36 to $1036.80 intraday, diverging from the positive product milestone announcement.
1d ago
Valuation

IONQ
IonQ announced a definitive agreement to acquire Elisity, a zero-trust cybersecurity startup, for up to $1.3 billion (Business Wire, 2026-10-12), marking a major strategic pivot into quantum-era cybersecurity. Despite the acquisition news, the stock fell 6.14% to $37.44, suggesting investor concerns about the deal's valuation, dilution, or strategic fit outweighed confidence in the quantum-cybersecurity thesis.
1d ago
Risk

SNDK
SanDisk shares fell 4.65% to $1,508.33 following a weekend report (cited by Google's AI Overview via Yahoo Finance) that U.S. authorities may permit Apple to source NAND flash memory from China's YMTC, intensifying competitive pressure on the company. The decline is also part of broader profit-taking across memory and semiconductor peers—including Micron and SK Hynix—as investors reduce exposure to high-valuation tech names ahead of earnings season.
1d ago
Valuation

CBRS
Cerebras stock fell 10.36% to $147.17, driven by OpenAI partnership concerns and share lockup pressures. According to Barron's, industry reports (SemiAnalysis) suggest OpenAI's GPT-6.1 Sol is using Nvidia GPUs rather than Cerebras hardware, undermining confidence in the key commercial relationship despite reassurances from CEO Sam Altman. Volume surged to 10.4M shares—2.96x the historical average at this point in the session—as approaching lockup expirations flood the market with newly eligible supply.
1d ago
Material / Earnings

PCVX
Vaxcyte, Inc. (PCVX) moved +10.19% from $64.78 to $71.38 on 2026-10-09. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move occurred on typical trading activity.
4d ago
Activity

HIMS
Hims & Hers reversed a prior-session decline, gaining 6.54% to $29.89 intraday. The bounce follows yesterday's 5.01% drop (Zacks, 2026-10-08), though no fresh catalyst emerged today; the rebound may reflect technical oversold conditions or short-covering after recent weakness. Volume remains at 1.0x normal for this session time.
4d ago
Valuation

JOBY
Joby Aviation fell 8.18% to $5.28 after a $116.9 million trade-secret verdict against the company favoring Aerosonic, combined with lingering investor concern over a $513.9 million stock offering announced recently (Yahoo Finance, Investors.com). Volume reached 24.5 million shares, 1.62x the time-adjusted average, reflecting elevated selling pressure alongside the legal setback and equity dilution.
4d ago
Activity

SCCO
Surging benchmark copper prices—driven by strong Asian industrial demand and South American supply constraints—lifted Southern Copper +5.02% to $208.64, according to the web catalyst. Institutional investors are rotating out of technology into inflation-hedged commodity assets, boosting SCCO as a primary copper play. Volume stands at 345,161 shares (0.57x expected for this time of day), below average.
4d ago
Activity

NET
Cloudflare shares rose 5.18% to $359.59, with the stock identified as a trending name by Zacks amid growing investor interest. Volume at 220 minutes into the session stands at 1.29M shares—74% of the expected daily average, consistent with normal intraday pacing. No company-specific news or catalyst event has been identified in today's trading.
4d ago
Valuation

CIEN
Ciena surged 4.94% to $446.96, driven by sector-wide bullish momentum in optical networking infrastructure following Marvell Technology's projection that the optical interconnect market could expand 60–70% through 2030—exceeding Ciena's own baseline forecasts (Zacks). The move also reflects investor rotation into high-speed data-center connectivity plays amid AI infrastructure buildout, with peers Corning and Coherent rising on the same tailwinds. Ciena's own recent fiscal Q3 results (record $1.67B revenue, +37% YoY, backlog approaching $8.5B) and long-term 30% revenue growth framework through fiscal 2029 underpin the optimism.
4d ago
Valuation

MOS
The Mosaic Company fell 4.84% to $18.77, hitting a new 52-week low, as potash market pressures, margin compression from elevated sulfur and ammonia costs, and technical weakness combined to weigh on the stock. Recent analyst downgrades (including actions by RBC Capital and S&P Global Ratings) have flagged persistent cost headwinds squeezing phosphate margins, while geopolitical discussions around Belarusian potash supply threaten pricing power. MOS has declined roughly 25% over the past month and now trades well below its 50-day and 200-day moving averages.
4d ago
Valuation

DDOG
Datadog rose 4.95% to $287.34, outperforming the broader software sector (+1.25%) on renewed institutional demand and sector-wide momentum in AI observability tools. According to the web catalyst synthesis, gains were driven by sympathetic rallies in related infrastructure peers (Fastly, Cloudflare) and continued institutional positioning ahead of Q3 earnings, with Farther Finance Advisors LLC adding to holdings (defenseworld.net). Volume was 0.81x normal for this time of session.
4d ago
Risk

LUMN
Lumen Technologies fell 6.12% to $5.22 intraday despite announcing a partnership with Eminence Grey to deliver sovereign AI infrastructure across the U.S., combining Eminence Grey's AI platform with Lumen's physical infrastructure and programmable network (PR Newswire, Oct 8). The market reaction diverged from the strategic announcement; volume stood at 1.54x the time-adjusted average, indicating normal trading activity for this point in the session.
4d ago
Activity

IBRX
ImmunityBio announced participation in the Piper Sandler Virtual Oncology Symposium, with Founder and Executive Chairman Dr. Patrick Soon-Shiong scheduled to present (Business Wire, 2026-10-08). The stock rose 5.40% to $10.45 on volume of 7.9M shares (1.63x historical average for this time of day), suggesting investor interest in the company's clinical or commercial updates ahead of the event.
4d ago
Valuation

SNAP
Snap Inc. (SNAP) rallied +6.91% to $6.26 intraday, with volume running 2.25x the expected rate for this time of session. No specific catalyst event appears in today's reporting; the move follows a recent period of volatility in which SNAP underperformed the S&P 500 on Dec 11, 2025 (down 3.54%) and Jun 10, 2026 (down 3.76%), though the stock rebounded sharply on Apr 1, 2026 (+14.43%) on acquisition news.
4d ago
Valuation

CRUS
Cirrus Logic shares fell 4.71% to $107.87, extending a broader pullback driven by multiple headwinds: pricing and margin pressures cited by Wall Street analysts (projected contraction from 18.1% to ~15.2% margins due to rising R&D costs and shifting product mix), softer-than-expected guidance despite recent earnings beats, cautious PC market outlook, and elevated customer concentration risk with Apple representing ~90% of revenues (finance.yahoo.com). Volume of 267K shares runs 1.39x the time-adjusted average, suggesting normal participation.
4d ago
Valuation

AAOI
Applied Optoelectronics rose 5.21% to $111.42 following a 247wallst.com report featuring a Wall Street analyst's call for the stock to double from depressed levels after a 6-month decline. Volume surged to 7.36M shares — 5.19x the typical intraday average at this time — signaling elevated retail and institutional interest in the name.
4d ago
Activity

OKTA
Okta rose 4.07% to $229.17, building on a 1.01% gain from the previous session (Zacks, 2026-10-08). The intraday move occurs on below-average volume of 1.18M shares (0.55x expected), suggesting modest participation.
4d ago
Risk

SWKS
Skyworks Solutions fell 6.09% to $75.83 intraday, dropping from the previous close of $80.75. The decline occurs as the company focuses on integrating Qorvo following the $22 billion combination that closed on October 5, per Yahoo Finance. No specific intraday catalyst was identified in available news flow; the move may reflect broader market dynamics or investor caution during the integration phase.
4d ago
Valuation

CHTR
Charter Communications fell 6.57% to $102.47 as the stock continues a multi-week decline driven by heavy debt concerns, rising long-term interest rates, and competitive pressures in broadband from fiber and fixed wireless providers. The sell-off, which accelerated through September (down 27% that month), has been reinforced by recent analyst downgrades and price-target cuts from firms including Oppenheimer and KeyBanc, pushing shares toward 52-week lows. Volume of 3.34M shares is 1.67x the time-adjusted average, reflecting elevated trading activity.
4d ago
Activity

ZS
Zscaler rose 3.78% to $225.00 on intraday strength following a 45% three-month rally driven by strong AI security demand, according to Zacks analysis published today. The gain occurred as the broader market declined, positioning ZS as a relative outperformer; volume data remains unreliable at this early stage of the session.
4d ago
Valuation

HPQ
HP Inc. (HPQ) fell 5.46% to $30.67 as the company issued a cautious 2027 outlook citing rising memory costs and projected mid-single-digit declines in global PC unit shipments, per the web catalyst. CFO Karen Parkhill anchored guidance to the lower end amid rising DRAM, NAND, and supply chain pressures.
4d ago
Valuation

MRNA
Moderna surged +11.51% to $219.68, driven by two catalysts: an exclusive report (New York Times, per web sources) detailing a major national public-private partnership to accelerate mRNA cancer vaccine development, and the company's official reinclusion in the Nasdaq-100 Index effective today. Volume traded 2.15x the historical average for this time of day, signaling broad institutional participation.
4d ago
Valuation

CCI
Crown Castle announced an $8.5 billion sale of its fiber and small cell businesses as part of a broad business reshaping (Yahoo Finance, Feb 11, 2026). The stock surged 14.28% to $78.73 on unusually heavy volume of 4.9 million shares (4.36x the time-adjusted expected average), signaling strong investor interest in the divestiture strategy.
4d ago
Valuation

SNOW
Snowflake rose 6.32% to $365.09 on the rollout of its "Agentic Marketplace Discovery" tool in public preview, which expands the platform's AI-driven capabilities via its Cortex Code assistant (CoCo). The move was amplified by a broad enterprise AI software sector rebound following an overnight pullback, and sustained by recent Wall Street price-target upgrades including Citi's $490 target. Volume of 4.1M shares ran 1.66x normal for this point in the session.
4d ago
Valuation

ASTS
AST SpaceMobile shares fell 13.91% to $49.01 as SpaceX secured a low-band spectrum deal from Grain Management, closing off a critical expansion pathway for ASTS, per 247wallst.com. The move was amplified by elevated volume (21.7M shares, 6.46x normal for this time of day), with shares sliding to near their 52-week low of $48.82.
4d ago
Valuation

HUM
Humana surged 11.84% after the Centers for Medicare & Medicaid Services released its final 2027 Medicare Advantage Star Ratings, showing 95% of HUM's Medicare Advantage members will be in 4-star or higher plans—a dramatic jump from 20% in 2026 (Reuters, Yahoo Finance). The company's flagship H5216 contract recovered to 4 stars from 3.5 stars, restoring eligibility for quality bonus payments affecting ~2.4 million members. Analyst Baird upgraded HUM from Neutral to Outperform and raised its price target to $596.
4d ago
Risk
T
T
AT&T fell 10.15% to $22.34 after SpaceX announced an $8 billion acquisition of nationwide low-band spectrum from Grain Management for Starlink Mobile, reshaping U.S. wireless competition (247wallst.com, seekingalpha.com). The spectrum deal pressures established carriers' competitive positioning in mobile services. A simultaneous iPhone Duo promotional announcement from AT&T did not offset the negative sentiment around the spectrum landscape shift.
4d ago
Valuation

VZ
Verizon fell 11.09% to $41.21 after SpaceX announced a definitive agreement to acquire nationwide 800 MHz low-band spectrum for ~$8 billion to power Starlink Mobile's satellite-to-phone service, according to 247wallst.com. The decline also reflects an analyst price target cut from Scotiabank (from $51.50 to $50.00 citing long-term sector disruption risks) and Verizon's ex-dividend date of October 9 ($0.7075 per share). Volume surged to 43.3M shares, 6.0x the 130-minute average, signaling institutional repositioning.
4d ago
Valuation

TMUS
SpaceX's Starlink expansion into mobile services with new spectrum access and FCC backing triggered a sharp selloff across wireless carriers. TMUS fell 12.43% from $171.31 to $150.01, with volume at 4.62x the time-adjusted average, as investors repriced competition risk from satellite-to-cell capabilities (ProactiveInvestors, GuruFocus). The move was part of a broader telecom sector decline affecting AT&T and Verizon as well.
4d ago
Valuation

AMT
American Tower rose 7.34% to $178.96, driven by a sector-wide rebound in communication infrastructure REITs following SpaceX's spectrum acquisition and renewed interest in tower and ground-network assets (investing.com, uk.investing.com). Investors are repricing cell tower operators as potential beneficiaries of hybrid satellite-terrestrial network strategies, with positive sentiment also building ahead of Q3 earnings on October 27.
4d ago
Risk

CBRS
Cerebras fell 6.87% to $163.02, retreating to its IPO price level. The decline follows commentary highlighting the company's dependence on a narrow customer base—roughly 80–85% of near-term revenue consensus through October 2026 concentrated with OpenAI—amid an otherwise bullish narrative about its inference cloud and differentiated chip architecture (Seeking Alpha). Volume of 5.5M shares ran 1.20x normal for this point in the session.
5d ago
Risk

LUMN
Lumen Technologies fell 6.35% to $5.54 despite announcing a partnership with Eminence Grey to deliver sovereign AI infrastructure across the U.S. (PR Newswire). The stock decline suggests the market reaction diverged from the partnership news, possibly reflecting broader concerns about near-term profitability—consensus estimates point to a loss of $0.22 per share at the next earnings report.
5d ago
Valuation

COHR
Coherent fell 10.53% to $299.31 as part of a sector-wide pullback in optical networking and AI infrastructure stocks following a strong recent run, according to Yahoo Finance. Profit-taking is driving the broader optics group lower after gains accumulated in high-growth names. Volume is at 1.11x expected levels for this point in the session.
5d ago
Risk

ASTS
AST SpaceMobile fell 6.19% to $56.90 as multiple class action lawsuit notices targeting the company circulated via PR Newswire, with investor deadline alerts from Robbins Geller Rudman & Dowd LLP and SueWallSt highlighting shareholder losses. Volume was elevated at 1.75x expected for the time of day, consistent with news-driven selling.
5d ago
Risk

GKOS
Glaukos announced an exclusive license agreement with RevOpsis Therapeutics to develop and commercialize RO-104, a first-in-class tri-specific biologic for retinal diseases (Business Wire). Despite the pipeline expansion, GKOS fell 12.63% to $150.43 from $172.18, on elevated volume of 850,206 shares (4.10x expected for 90 minutes into the session), suggesting investor concern about deal terms, capital requirements, or near-term financial impact.
5d ago
Risk

CORZ
Core Scientific fell 3.64% to $15.36 despite positive AMD approval news reported by Seeking Alpha, which framed the situation as a buying opportunity amid a broader meltdown. Volume is tracking 1.14x normal for this point in the session, suggesting modest algorithmic or profit-taking activity rather than panic selling.
5d ago
Valuation

OKLO
Oklo Inc. declined 3.61% to $35.49 amid ongoing valuation concerns and execution risk typical of pre-revenue nuclear developers, according to the web_catalyst synthesis. Piper Sandler reiterated an Overweight rating and $55 price target following recent facility visits (ng.investing.com), yet retail sentiment remains cautious about long NRC approval timelines and commercialization delays. Volume of 2.73M shares is 1.27x the time-adjusted average, indicating normal intraday activity.
5d ago
Risk

AAOI
Applied Optoelectronics fell 9.84% to $110.48, reversing recent momentum after a 16.6% one-month rally driven by AI-driven optical demand (Zacks, 2026-10-07). The sharp intraday decline occurred on elevated volume of 2.47x the session average, suggesting institutional selling pressure despite the prior optimism around supply and competitive headwinds cited by analysts.
5d ago
Valuation

CMG
Chipotle shares surged 4.47% to $32.15 after a Financial Times report revealed that Starbucks explored a potential takeover of the burrito chain, according to sources cited by the FT. The deal speculation centered on Starbucks CEO Brian Niccol, who previously led Chipotle's growth phase, and valued the target near $39 billion. Volume spiked to 10.38x the historical average for this time of day, reflecting investor interest in the M&A story.
5d ago
Risk

CIFR
Cipher Mining fell 5.63% to $13.74 in early trading with no specific catalyst apparent in today's session. The stock's movement follows a pattern of volatility tied to cryptocurrency price swings—historically, CIFR has tracked Bitcoin and other digital assets closely (Motley Fool). Without confirmed intraday news or earnings, the decline may reflect broader crypto market weakness or profit-taking, though volume data remains unreliable at this early stage.
5d ago
Valuation

GLXY
Galaxy Digital fell 5.98% to $20.12 after Goldman Sachs cut its price target to $24, according to web sources tracking the intraday move. The stock is trading 16% below the new Goldman target, reflecting investor concern over the firm's strategic positioning amid crypto regulatory uncertainty and its transition toward AI data-center infrastructure. Volume of 5.15M shares is running 1.33x the historical average at this time of day, indicating normal participation.
5d ago
Valuation

VSAT
Viasat fell 3.68% to $68.26, citing an active spectrum dispute tied to satellite coordination and mixed investor sentiment following a recent options surge (Yahoo Finance). The decline comes 29 days ahead of earnings, with no volume confirmation yet available this early in the session.
5d ago
Valuation

RVMD
Revolution Medicines fell 6.19% to $188.43 as investors engaged in profit-taking on high-flying biotech stocks amid technical weakness and recent insider selling disclosures, according to web sources tracking the October 8 session. The decline occurred despite the company's announcement of patient enrollment in its Phase 3 RASolute 309 trial for metastatic pancreatic cancer, suggesting the positive operational update was overshadowed by sector-wide valuation digestion following a sustained multi-month rally.
5d ago
Risk

HUT
Hut 8 Corp. fell 11.69% to $78.86 on no identified intraday catalyst; the only newsflow was a PR Newswire announcement scheduling Q3 2026 earnings for November 3, 2026, which is a routine procedural item. Volume is trading at 1.49x the 210-minute average, within normal range for this time of session.
5d ago
Risk

RIOT
Riot Platforms filed a material event (8-K) today, coinciding with a 9.60% intraday decline to $16.76. Volume surged to 23.95M shares—2.03x the time-adjusted average—signaling heightened reaction to the filing. The company has faced persistent headwinds including negative cash flows and share dilution, per recent analyst commentary (Seeking Alpha, Feb 2025).
5d ago
Material / Earnings

LEVI
Levi Strauss & Co. (LEVI) reported EPS of $0.48 vs. consensus estimate of $0.36, beating by 34.0% on 2026-10-07.
6d ago
Material / Earnings

APLD
Applied Digital Corp. (APLD) reported EPS of $-0.01 vs. consensus estimate of $-0.30, beating expectations by 96.6%.
6d ago
Risk

CIFR
Cipher Mining (CIFR) declined 5.97% to $14.57, continuing a pattern of sharp sell-offs that has marked the stock since a significant Q2 2026 earnings miss (investing.com). The stock has now posted double-digit losses on multiple recent trading days, most recently a 10.82% drop on Jul 16, 2026 (Zacks). Volume is tracking at 0.96x historical average, indicating no unusual accumulation or distribution at this time.
6d ago
Risk

APLD
Applied Digital fell 4.93% to $24.09 ahead of tomorrow's earnings release, despite announcing its first international data center deal, according to 247wallst.com. The decline occurred on elevated volume (3.01x typical for this time of day), with peer data-center operators Iren and Core Scientific also dropping ~4%, suggesting sector-wide pressure ahead of earnings.
6d ago
Risk

AGCO
AGCO fell 5.03% to $110.35 in early trading with no same-day catalyst evident in available sources. The company has announced an upcoming third-quarter 2026 earnings release (scheduled for 2026-10-30 per PR Newswire), and recent commentary highlights a strategic shift toward precision agriculture and technology-driven growth, but no new concrete event or guidance change is documented today to explain the intraday decline.
6d ago
Valuation

IESC
IES Holdings shares fell 9.84% to $308.20, driven by profit-taking after a sustained rally, valuation concerns flagged by financial models, and post-acquisition digestion following the DBM Global acquisition, per web research. Volume at 178,222 shares (240 min into session) ran 1.18x the historical average for this time of day.
6d ago
Risk

CW
Curtiss-Wright Corporation filed a material event on Form 8-K today, triggering a 5.21% intraday decline from $553.35 to $524.54. The specific nature of the event was not disclosed in available evidence, but the same-day filing and sharp move indicate a significant corporate development. Volume reliability cannot yet be assessed within the first 10 minutes of the session.
6d ago
Stocks tracked
987
Total changes
34222
Most active
MU
Avg 30D change
-3.18%
